Prolymphocytic leukaemia and Hodgkin's lymphoma

Eur J Haematol. 2002 Sep;69(3):182-4. doi: 10.1034/j.1600-0609.2002.02758.x.

Abstract

We describe a case of B-prolymphocytic leukaemia (B-PLL) who, following a long-lasting remission with fluradabine, developed a Hodgkin's lymphoma (HL) with bone marrow involvement. A 75-yr-old male was found to have a lymphocytosis [white blood cell (WBC) count = 146 x 10(9) L(-1)], small volume axillary lymphadenopathy, and hepatosplenomegaly. The majority of circulating lymphocytes had a round nucleus and prominent single nucleolus. The patient did not respond to chlorambucil and then received fludarabine, achieving a good response lasting for 5 yr, when he manifested with B symptoms and pancytopenia. A diagnosis of HL in the bone marrow was made based on histology (Reed-Sternberg cells) and immunohistochemistry (CD30+, CD15+). Epstein-Barr virus (EBV) studies were negative. The patient was treated with chemotherapy but died 6 months later from disease progression.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use
  • Bone Marrow / pathology
  • Hodgkin Disease* / pathology
  • Humans
  • Leukemia, Prolymphocytic* / drug therapy
  • Leukemia, Prolymphocytic* / pathology
  • Leukemia, Prolymphocytic* / physiopathology
  • Male
  • Neoplasms, Second Primary*
  • Remission Induction

Substances

  • Antineoplastic Agents